Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data. Read more about Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data.
Polymorphisms in Tumor Necrosis Factor-α Are Associated With Higher Anxiety Levels in Women After Breast Cancer Surgery. Read more about Polymorphisms in Tumor Necrosis Factor-α Are Associated With Higher Anxiety Levels in Women After Breast Cancer Surgery.
Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network. Read more about Practice patterns in the delivery of radiation therapy after mastectomy among the University of California Athena Breast Health Network.
Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2. Read more about Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.
Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation. Read more about Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation.
Intraductal therapy of ductal carcinoma in situ: a presurgery study. Read more about Intraductal therapy of ductal carcinoma in situ: a presurgery study.
Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Read more about Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer.
The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Read more about The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ.
Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancer. Read more about Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancer.
Challenging clinical scenarios: treatment of patients with triple-negative or basal-like metastatic breast cancer. Read more about Challenging clinical scenarios: treatment of patients with triple-negative or basal-like metastatic breast cancer.
